5-oxoproline-induced anion gap metabolic acidosis after an acute acetaminophen overdose

Journal of the American Osteopathic Association

Volumn 110, Issue 9, 2010, Pages 545-551

  Lawrence, David T ^a   Bechtel, Laura K ^a   Charlton, Nathan P ^a   Holstege, Christopher P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANALGESIC AGENT; PARACETAMOL; PYROGLUTAMIC ACID; SCAVENGER;

ACID BASE BALANCE; ACIDOSIS; ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; METABOLISM;

ACETAMINOPHEN; ACETYLCYSTEINE; ACID-BASE EQUILIBRIUM; ACIDOSIS; ACUTE DISEASE; ADULT; ANALGESICS, NON-NARCOTIC; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; PYRROLIDONECARBOXYLIC ACID;

EID: 79958265838     PISSN: 00986151     EISSN: 19451997     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ala A, Schiano T, Burroughs A, Keshav S. Recognition of nonhepatic coma in the setting of acetaminophen overdose. Dig Dis Sci. 2004;49(11-12):1977-1980.
2. Gray TA, Buckley BM, Vale JA. Hyperlactataemia and metabolic acidosis following paracetamol overdose. Q J Med. 1987;65(246):811-821.
3. Esterline RL, Ray SD, Ji S. Reversible and irreversible inhibition of hepatic mitochondrial respiration by acetaminophen and its toxic metabolite, Nacetyl-p-benzoquinoneimine (NAPQI). Biochem Pharmacol. 1989;38(14):2387-2390.
4. Esterline RL, Ji S. Metabolic alterations resulting from the inhibition of mitochondrial respiration by acetaminophen in vivo. Biochem Pharmacol. 1989;38(14):2390-2392.
5. Pitt JJ, Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem. 1998;44(7):1497-1503.
6. Croal BL, Glen AC, Kelly CJ, Logan RW. Transient 5-oxoprolinuria (pyro -glutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. Clin Chem. 1998;44(2):336-340.
7. Brooker G, Jeffery J, Nataraj T, Sair M, Ayling R. High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): association with prescription drugs and malnutrition. Ann Clin Biochem. 2007;44(4):406-409.
8. Flanagan RJ, Mant TG. Coma and metabolic acidosis early in severe acute paracetamol poisoning. Hum Toxicol. 1986;5(3):179-182.
9. Koulouris Z, Tierney MG, Jones G. Metabolic acidosis and coma following a severe acetaminophen overdose. Ann Pharmacother. 1999;33(11):1191-1194.
10. Mendoza CD, Heard K, Dart RC. Coma, metabolic acidosis and normal liver function in a child with a large serum acetaminophen level. Ann Emerg Med. 2006;48(5):637.
11. Roth B, Woo O, Blanc P. Early metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med. 1999;33(4):452-456.
12. Steelman R, Goodman A, Biswas S, Zimmerman A. Metabolic acidosis and coma in a child with acetaminophen toxicity. Clin Pediatr (Phila). 2004;43(2):201-203.
13. Kortmann W, Van Agtmael MA, van Diessen J, Kanen BL, Jakobs C, Nanayakkara PW. 5-Oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors. Neth J Med. 2008;66(8):354-357.
14. Meister A. The γ-glutamyl cycle: diseases associated with specific enzyme deficiencies. Ann Intern Med. 1974;81(2):247-253.
15. Njålsson R. Glutathione synthetase deficiency. Cell Mol Life Sci. 2005;62(17):1938-1945.
16. Hammarqvist F, Luo JL, Cotgreave IA, Andersson K, Wernerman J. Skeletal muscle glutathione is depleted in critically ill patients. Crit Care Med. 1997;25(1):78-84.
17. Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med. 2001;29(4):870-877.
18. Vendemiale G, Grattagliano I, Altomare E, Turturro N, Guerrieri F. Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat. Biochem Pharmacol. 1996;52(8):1147-1154.
19. Dimova S, Hoet PH, Nemery B. Paracetamol (acetaminophen) cytotoxicity in rat type II pneumocytes and alveolar macrophages In Vitro. Biochem Pharmacol. 2000;59(11):1467-1475.
20. Fenves AZ, Kirkpatrick HM 3rd, Patel VV, Sweetman L, Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol. 2006;1(3):441-447.
21. Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL. An unusual cause of severe metabolic acidosis. Med J Aust. 2006;185(4):223-225.
22. Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med. 2000;28(6):1803-1807.
23. Rolleman EJ, Hoorn EJ, Didden P, Zietse R. Guilty as charged: unmeasured urinary anions in a case of pyroglutamic acidosis. Neth J Med. 2008;66(8):351-353.
24. Bonham JR, Rattenbury JM, Meeks A, Pollitt RJ. Pyroglutamicaciduria from vigabatrin. Lancet.1989;1(8652):1452-1453.
25. Yale SH, Mazza JJ. Anion gap acidosis associated with acetaminophen. Ann Intern Med. 2000;133(9):752-753.
26. Tailor P, Raman T, Garaganta CL, et al. Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid). Am J Kidney Dis. 2005;46(1):e4-e10. doi:10.1053/j.ajkd.2005.03.021.
27. Ghauri FY, McLean AE, Beales D, Wilson ID, Nicholson JK. Induction of 5-oxoprolinuria in the rat following chronic feeding with N-acetyl 4-aminophenol (paracetamol). Biochem Pharmacol. 1993;46(5):953-957.
28. Mizock BA, Belyaev S, Mecher C. Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid. Intensive Care Med. 2004;30(3):502-505.
29. Hodgman MJ, Horn JF, Stork CM, et al. Profound metabolic acidosis and oxoprolinuria in an adult. J Med Toxicol. 2007;3(3):119-124.
30. Humphreys BD, Forman JP, Zandi-Nejad K, Bazari H, Seifter J, Magee CC. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. Am J Kidney Dis. 2005;46(1):143-146.
31. Atkuri, KR, Mantovani JJ, Herzenberg LA. N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355-359.